SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-068400
Filing Date
2010-07-27
Accepted
2010-07-27 12:17:14
Documents
8
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c03612e10vq.htm 10-Q 463848
2 EX-10.1 2005 STOCK INCENTIVE PLAN, AS AMENDED c03612exv10w1.htm EX-10.1 44566
3 EX-10.2 FIRST AMENDMENT OF LICENSE AGREEMENT, DATED MAY 20, 2010, BETWEEN VIIV H c03612exv10w2.htm EX-10.2 16229
4 EX-10.3 FOURTH AMENDMENT TO LEASE, DATED JUNE 29, 2010, BETWEEN RB KENDALL FEE, c03612exv10w3.htm EX-10.3 18079
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO c03612exv31w1.htm EX-31.1 5801
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO c03612exv31w2.htm EX-31.2 5798
7 EX-32.1 SECTION 906 CERTIFICATION OF CEO c03612exv32w1.htm EX-32.1 3539
8 EX-32.2 SECTION 906 CERTIFICATION OF CFO c03612exv32w2.htm EX-32.2 3540
  Complete submission text file 0000950123-10-068400.txt   562836
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 10970877
SIC: 2834 Pharmaceutical Preparations